Skip to main content
PMC home page
Journal of Ayurveda and Integrative Medicine logoLink to Journal of Ayurveda and Integrative Medicine
. 2017 Sep 15;8(4):215–217. doi: 10.1016/j.jaim.2017.02.003

Effects of anti-lipid peroxidation of Punica granatum fruit extract in endothelial cells induced by plasma of severe pre-eclamptic patients

Isri Nasifah a,∗, Setyawati Soeharto b, Mukhamad Nooryanto c
PMCID: PMC5747508  PMID: 28928008

Abstract

Preeclampsia is a pregnancy disorder characterized by hypertension and proteinuria. This disorder involves oxidative stress and changes in endothelial homeostasis. This study was aimed to seek whether an ethanolic extract of Punica granatum fruit inhibits 8-iso-PGFα formation and modulates nitric oxide (NO) in endothelial cells induced by plasma from pre-eclamptic patients. Endothelial cells were cultured from human umbilical vein endothelial cells. At confluence, endothelial cells were divided into five groups, which included endothelial cells exposed to 2% plasma from normal pregnancy (NP), endothelial cells exposed to 2% plasma from pre-eclamptic patients (PP), endothelial cells exposed to PP in the presence of ethanolic extract of P. granatum (PP + PG) at the following three doses: 14; 28; and 56 ppm. Analysis of 8-iso-PGFα was done by immunoassay technique. Analysis of NO level was done by colorimetric technique. Plasma from PP significantly increased 8-iso-PGFα level compared to cells treated by normal pregnancy plasma. This increase in 8-iso-PGFα was significantly (p < 0.05) attenuated by all doses treatments of P. granatum extract. The level of NO was insignificant (p > 0.05) between groups. P. granatum fruit extract protects endothelial cells from oxidative stress induced by plasma from pre-eclamptic patients.

Keywords: Oxidative damage, Oxidative stress, Endothelial, Hypertension

Highlights

  • •

    Endothelial cells induce by preeclamptic plasma.

  • •

    8-iso-PGFα level significantly increased.

  • •

    NO level insignificantly changed.

  • •

    All doses of Theobroma cacao attenuated this 8-iso-PGFα increase.

1. Introduction

Pre-eclampsia is a multifactorial disorder which is underlain by a composite of genetic and environmental factors [1]. This disease causes hypertension and proteinuria symptoms which occur after 20 weeks of pregnancy. The pathogenesis of this syndrome is still not fully understood. It is constituted by placental dysregulation triggered by a mismatch of trophoblast invasion and endothelial cell dysfunction [2], [3], [4]. One of the important events in the development of pre-eclampsia is the formation of free radicals and oxidative stress [5], [6].

Lipid peroxidation is a reaction between reactive oxygen compound and lipid. In particular, the peroxidation reaction between prostaglandin-like compounds and free radicals can form F2-isoprostane [7], [8], [9]. In case of pre-eclampsia, F2-isoprostane is found to increase in the placenta and urine [10], [11]. This compound is not only a marker of peroxidation, but also a mediator of oxidation injury. One of the effects of the reactivity of F2-isoprostane is triggering vasoconstriction of blood vessels, allegedly through reaction with nitric oxide [12]. NO is a potent vasodilator which has been proven in both in vivo and in vitro studies; inhibition of NO production triggers pre-eclampsia-like syndrome [13], [14], although studies show inconsistent results [15], [16], [17].

In order to reduce morbidity and mortality from pre-eclampsia few herbs have been studied, [18], [19], [20], [21]. Punica granatum is a fruit native to Indonesia with high polyphenol content [22]. In Indonesia and India, this plant is used for it's astringent, anti-parasitic, analgesic, and antipyretic properties [23], [24], [25]. The high content of polyphenols underlies the antioxidant properties of this plant [26], [27], [28]. Up till now, the application of P. granatum plant in pre-eclampsia has not been done. Therefore, this study focuses on analyzing the effects of P. granatum against lipid peroxidation and changes in NO in endothelial cells exposed to plasma of pre-eclamptic patients.

2. Materials and methods

2.1. Isolation and culture of human umbilical vein endothelial cells (HUVECs)

This was an in vitro experimental study using Human Umbilical Vein Endothelial Cells (HUVECs). The technique of isolation and culture of HUVECs was performed in pursuance of the detailed method in a previous study [29]. After having reached confluence, HUVECs were divided into five groups, including control group (group OF HUVECs exposed to plasma isolated from normal pregnancy), group of HUVECs exposed to 2% plasma from pre-eclamptic patients, and group of HUVECs exposed to 2% plasma from pre-eclamptic patients along with the administration of ethanol extracts of P. granatum fruit in doses of 14, 28, and 56 ppm.

2.2. Isolation of plasma from severe pre-eclamptic patients

Isolation of plasma from severe pre-eclamptic patients was performed in pursuance of the method in a previous study [29]; this procedure received an approval from the Health Research Ethics Committee, Faculty of Medicine, University of Brawijaya, Malang, Indonesia. The criteria for subject were hypertension occurring after 20 weeks' gestation as assessed by blood pressure ≥140/90 mmHg, increase ≥30/15 mmHg, diastolic ≥90 mmHg measured in a sitting position, cuff with the right size. In addition found uria protein ≥2+ with dipstick examination or ≥300 mg/dL in urine 24 hours. The dose of 2% pre-eclampsia plasma was the optimum dose capable of providing a response to a decrease in endothelial relaxation from blood vessels based on a previous study [29].

2.3. Extraction of P. granatum

P. granatum fruit was obtained from Bandungan Village, Semarang, Central Java, Indonesia. Fruit having been washed clean was then peeled and put in the oven (40 °C–60 °C) to be dried (free water content). After pomegranate fruit was dried, the fruit was mashed using a blender. 100 g of it was then put in an Erlenmeyer flask sized ±1 L and soaked in 900 ml of ethanol. This mixture was deposited for one night until being precipitated. The top layer was taken by filtration. Evaporation was carried out and the results obtained were stored in a freezer.

2.4. Analysis of 8-iso-PGFα levels

Levels of 8-iso prostaglandin F2α were analyzed in the medium of HUVECs. Analysis was conducted by Human 8-iso prostaglandin F2α (8-iso-PGFα) (Abcam, catalog number ab 133025). Analysis procedures were performed in accordance with the complete procedures in the kit.

2.5. Analysis of NO levels

Total levels of nitric oxide were analyzed in the medium of HUVECs. The analysis was conducted with a total of nitric oxide and nitrate/nitrite assay (R&D system; catalog KGE001). Analysis procedures were performed in accordance with the complete procedures in the kit.

2.6. Ethics

This study has passed an ethical review and was approved by the Health Research Ethics Committee, Faculty of Medicine, University of Brawijaya, Malang, Indonesia.

2.7. Statistical analysis

Levels of 8-iso prostaglandin F2α and NO have been shown in mean ± standard deviation. Differences between treatment groups have been analyzed using one-way ANOVA test with the assistance of SPSS 17.0 statistical package software. If significance in the group was found in the ANOVA test, post hoc test was conducted. Value of p < 0.05 was set as a value of statistically significant difference.

3. Results

Table 1 shows the levels of 8-iso-PGFα as a marker of lipid peroxidation in various study groups. The levels of 8-iso-PGFα were significantly higher in the group of HUVEC cells exposed to plasma of pre-eclampsia than the group of HUVECs exposed to normal pregnancy plasma (p < 0.05). All three doses of P. granatum lower the levels of 8-iso-PGFα significantly compared with the group of HUVECs cell exposed to plasma of pre-eclampsia (p < 0.05). Of these three doses, triggering a decline reaching levels of 8-iso-PGFα is in the group of HUVECs exposed to normal pregnancy plasma (p > 0.05).

Table 1.

A level of 8-iso-PGFα and NO in endothelial cells induced by plasma pre-eclamptic patients.

Level NP PP PP + P. granatum
14 ppm 28 ppm 56 ppm
8-iso-PGFα (pg/mL) 63.42 ± 31.43 495.22 ± 110.06a 220.40 ± 90.38ab 108.28 ± 89.07b 200.89 ± 56.00b
NO (μmol/L) 40.87 ± 66.17 4.01 ± 0.88 5.04 ± 1.17 5.05 ± 2.3 5.33 ± 0.97
Open in a new tab

Note: values are presented as mean ± SD; ap < 0.05; in comparison with the NP group; bp < 0.05; in comparison with the PP group; NP: plasma from normal pregnancy; PP: plasma from pre-eclamptic patients; NO: nitric oxide; μmol/L: micromol/liter; ppm: parts per million; pg/mL: picogram/milliliter.

NO levels from various study groups are also shown in Table 1. The NO levels from various study groups showed no significant differences (p > 0.05).

4. Discussion

Depending on the levels of free radicals, a variety of redox-sensitive transcription factors will be activated and trigger intracellular biological response [30]. In this study, the levels of 8-iso-PGFα increased significantly in the group of HUVECs exposed to the plasma of pre-eclamptic women compared with the group of HUVECs exposed to normal pregnancy plasma (p < 0.05). This indicates that the plasma of patients with pre-eclampsia are pro-oxidative which can trigger lipid peroxidation as one form of oxidative stress in endothelial cells. This is consistent with previous findings that a variety of factors, including free radicals were detected in the maternal circulation of pre-eclamptic patients [29], [31], [32], [33]. In this study, a variety of active ingredients contained in P. granatum extracts could reduce the levels of 8-iso-PGFα significantly, reaching levels comparable to HUVECs exposed to plasma from normal pregnancy (p < 0.05). This indicates that the antioxidant activity of P. granatum reacts with free radicals in the plasma of pre-eclamptic patients thus inhibiting lipid peroxidation. This study is consistent with previous findings that the various contents of P. granatum (ellagic acid, gallotannins, and anthocyanins (cyanidin, delphinidin, and pelargonidin glycosides), as well as other flavonoids (quercetin, kaempferol and luteolin glycosides) are antioxidant [26], [27], [28], [34].

For the NO levels are still contradictory in pre-eclampsia. Low levels of maternal NO were found due to existence of endogenous inhibitor(s) in the production of NO. The other studies found the opposite results [35], [36], [37]. In this study, the levels of NO from various study groups showed no significant differences (p > 0.05). This indicates that the plasma of normal pregnancy and pre-eclampsia could not modulate the production of NO. Likewise the active ingredients of P. granatum could not modulate the production of NO in HUVECs cell exposed to plasma of pre-eclampsia. On the other side, it also becomes a foothold for subsequent studies that the exposure models of plasma of pre-eclamptic patients cannot trigger endothelial dysfunction characterized by decreased levels of NO.

5. Conclusion

It can be concluded that the extract of P. granatum was able to inhibit lipid peroxidation in the HUVECs cell model given exposure to plasma of pre-eclamptic patients. Thus, extract of P. granatum can be a candidate for herbal antioxidant for pre-eclampsia.

Conflict of interest

None.

Acknowledgements

The authors would like to thank consultants and technicians in Biomedical and Molecular Physiology Laboratory, Faculty of Medicine, University of Brawijaya, Malang, Indonesia for sharing their expertise.

Footnotes

Peer review under responsibility of Transdisciplinary University, Bangalore.

References

  • 1.Molvarec A., Jermendy A., Nagy B., Kovacs M., Varkonyi T., Hupuczi P. Association between tumor necrosis factor (TNF)-α G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clinica Chimica Acta. 2008;392(1–2):52–57. doi: 10.1016/j.cca.2008.03.009. [DOI] [PubMed] [Google Scholar]
  • 2.Sibai B.M. Intergenerational factors. A missing link for preeclampsia, fetal growth restriction, and cardiovascular disease? Hypertension. 2008;7:7. doi: 10.1161/HYPERTENSIONAHA.107.104489. [DOI] [PubMed] [Google Scholar]
  • 3.Merviel P., Carbillon L., Challier J.C., Rabreau M., Beaufils M., Uzan S. Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol. 2004;115(2):134–147. doi: 10.1016/j.ejogrb.2003.12.030. [DOI] [PubMed] [Google Scholar]
  • 4.Padmini E., Venkatraman U., Srinivasan L. Mechanism of JNK signal regulation by placental HSP70 and HSP90 in endothelial cell during preeclampsia. Toxicol Mech Methods. 2012;22(5):367–374. doi: 10.3109/15376516.2012.673091. [DOI] [PubMed] [Google Scholar]
  • 5.Hung T.H., Burton G.J. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol. 2006;45:189–200. doi: 10.1016/S1028-4559(09)60224-2. [DOI] [PubMed] [Google Scholar]
  • 6.Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999;222:222–235. doi: 10.1177/153537029922200305. [DOI] [PubMed] [Google Scholar]
  • 7.Moore K., Roberts L.J. Measurement of lipid peroxidation. Free Radic Res. 1998;28:659–671. doi: 10.3109/10715769809065821. [DOI] [PubMed] [Google Scholar]
  • 8.Morrow J.D., Scruggs J., Chen Y., Zackert W.E., Roberts L.J. Evidence that the E2-isoprostane, 15-E2t-isoprostane (8-iso-prostaglandin E2) is formed in vivo. J Lipid Res. 1998;39:1589–1593. [PubMed] [Google Scholar]
  • 9.Roberts L.J., Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 1998;273:13605–13612. doi: 10.1074/jbc.273.22.13605. [DOI] [PubMed] [Google Scholar]
  • 10.Walsh S.W., Vaughan J.E., Wang Y., Roberts L.J. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000;14:1289–1296. doi: 10.1096/fj.14.10.1289. [DOI] [PubMed] [Google Scholar]
  • 11.Peter S.T., Scholl T.O., Schluter M.D., Leskiw M.J., Chen X., Spur B.W. Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res. 2008;42:841–848. doi: 10.1080/10715760802510069. [DOI] [PubMed] [Google Scholar]
  • 12.Cracowski J.L., Durand T. Cardiovascular pharmacology and physiology of the isoprostanes. Fundam Clin Pharmacol. 2006;20(5):417–427. doi: 10.1111/j.1472-8206.2006.00435.x. [DOI] [PubMed] [Google Scholar]
  • 13.Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  • 14.Molnar M., Suto T., Toth T., Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994;170:1458–1466. doi: 10.1016/s0002-9378(94)70179-2. [DOI] [PubMed] [Google Scholar]
  • 15.Diejomaoh F.M.E., Omu A.E., Al-Busiri N., Taher S., Al-Othman S., Fatinikun T. Nitric oxide production is not altered in preeclampsia. Arch Gynecol Obstet. 2004;269:237–243. doi: 10.1007/s00404-002-0465-6. [DOI] [PubMed] [Google Scholar]
  • 16.Sladek S.M., Magness R.R., Conrad K.P. Nitric oxide and pregnancy. Am J Physiol. 1997;272:R441–R463. doi: 10.1152/ajpregu.1997.272.2.R441. [DOI] [PubMed] [Google Scholar]
  • 17.Shaamash A.H., Elsnosy E.D., Makhlouf A.M., Zakhari M.M., Ibrahim O.A., Eldien H.M. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, preeclampsia and eclampsia. Int J Gynaecol Obstet. 2000;68:207–214. doi: 10.1016/s0020-7292(99)00213-1. [DOI] [PubMed] [Google Scholar]
  • 18.Souza C.O., Peraçoli M.T., Weel I.C., Bannwart C.F., Romao M., Nakaira-Takahaqi E. Hepatoprotective and anti-inflammatory effects of silibinin on experimental preeclampsia induced by l-NAME in rats. Life Sci. 2012;91(5–6):159–165. doi: 10.1016/j.lfs.2012.06.036. [DOI] [PubMed] [Google Scholar]
  • 19.Takei H., Nakai Y., Hattori N., Yamamoto M., Takeda S., Yamamoto M. The herbal medicines Saireito and Boiogito improve the hypertension of pre-eclamptic rats induced by Nω-Nitro-l-arginine methyl ester. Phytomedicine. 2007;14(9):591–600. doi: 10.1016/j.phymed.2007.01.009. [DOI] [PubMed] [Google Scholar]
  • 20.Giorgi V.S., Peracoli M.T., Peracoli J.C., Witkin S.S., Bannwart-Castro C.F. Silibinin modulates the NF-κb pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women. J Reprod Immunol. 2012;95(1–2):67–72. doi: 10.1016/j.jri.2012.06.004. [DOI] [PubMed] [Google Scholar]
  • 21.Takei H., Nakai Y., Hattori N., Yamamoto M., Kurauchi K., Sasaki H. The herbal medicine Toki-shakuyaku-san improves the hypertension and intrauterine growth retardation in preeclampsia rats induced by Nω-nitro-L-arginine methyl ester. Phytomedicine. 2004;11(1):43–50. doi: 10.1078/0944-7113-00332. [DOI] [PubMed] [Google Scholar]
  • 22.Qu W., Breksa A.P., Pan Z., Ma H. Quantitative determination of major polyphenol constituents in pomegranate products. Food Chem. 2012;132:1585–1591. doi: 10.1016/j.foodchem.2011.11.106. [DOI] [PubMed] [Google Scholar]
  • 23.Alper N., Acar J. Removal of Phenolic compounds in pomegranate juices using ultrafiltration and laccase-ultrafiltration combinations. Nahrung. 2004;48(3):184–187. doi: 10.1002/food.200200258. [DOI] [PubMed] [Google Scholar]
  • 24.Mudzhiri M.S. Punica granatum bark extract as a therapeutic agent in tapeworm infection. Med Parazitol. 1954;4:311–313. [PubMed] [Google Scholar]
  • 25.Lee C.J., Chen L.G., Lian W.L., Wang C.C. Anti-inflammatory effects of Punica granatum linne in vitro and in vivo. Food Chem. 2010;118:315–322. [Google Scholar]
  • 26.Bekir J., Mars M., Souchard J.P., Bouajila J. Assessment of antioxidant, anti-inflammatory, anti-cholinesterase and cytotoxic activities of pomegranate (Punica granatum) leaves. Food and Chem Toxicol. 2013;55:470–475. doi: 10.1016/j.fct.2013.01.036. [DOI] [PubMed] [Google Scholar]
  • 27.Aviram M., Dornfeld L., Rosenblat M., Volkova N., Kaplan M., Coleman R. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000;71:1062–1076. doi: 10.1093/ajcn/71.5.1062. [DOI] [PubMed] [Google Scholar]
  • 28.Kaplan M., Hayek T., Raz A., Coleman R., Dornfeld L., Vaya J. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr. 2001;131:2082–2089. doi: 10.1093/jn/131.8.2082. [DOI] [PubMed] [Google Scholar]
  • 29.Abimulyani Y., Nurdiana N., Baktiyani S.C.W. Syzygium cumini reduces oxidative stress and matrix metalloproteinase-2 level in endothelial cells induced by plasma from preeclamptic patients. J Exp Integr Med. 2014;4(2):89–92. [Google Scholar]
  • 30.Glorie G., Legrand-Poels S., Piette J. NF-κB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol. 2006;72:1493–1505. doi: 10.1016/j.bcp.2006.04.011. [DOI] [PubMed] [Google Scholar]
  • 31.Wataganara T., Bianchi D.W. Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann N Y Acad Sci. 2004;1022:90–99. doi: 10.1196/annals.1318.015. [DOI] [PubMed] [Google Scholar]
  • 32.Gänshirt D., Smeets F.W., Dohr A., Walde C., Steen I., Lapucci C. Enrichment of fetal nucleated red blood cells from the maternal circulation for prenatal diagnosis: experiences with triple density gradient and MACS based on more than 600 cases. Fetal Diagn Ther. 1998;13(5):276–286. doi: 10.1159/000020854. [DOI] [PubMed] [Google Scholar]
  • 33.Swinkels D.W., de Kok J.B., Hendriks J.C.M., Wiegerinck E., Zusterzeel P.L.M., Steegers E.A.P. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem. 2002;48:650–653. [PubMed] [Google Scholar]
  • 34.Longtin R. The pomegranate: nature's power fruit? J Natl Cancer Inst. 2003;95:346–348. doi: 10.1093/jnci/95.5.346. [DOI] [PubMed] [Google Scholar]
  • 35.Seligman S.P., Buyon J.P., Clancy R.M., Young B.K., Abramson S.B. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 1994;171:944–948. doi: 10.1016/s0002-9378(94)70064-8. [DOI] [PubMed] [Google Scholar]
  • 36.Fickling S.A., Williams D., Vallance P., Nursey S.S., Whitley G.S. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet. 1993;342:242–243. doi: 10.1016/0140-6736(93)92335-q. [DOI] [PubMed] [Google Scholar]
  • 37.Baker P.N., Davidge S.T., Roberts J.M. Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension. 1995;26:244–248. doi: 10.1161/01.hyp.26.2.244. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Ayurveda and Integrative Medicine are provided here courtesy of Elsevier

RESOURCES